RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC, covering 2019-01-25 to 2019-01-25. Get the full timeline:
Most recent: FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)